Phase 3 Clinical Trials

Capecitabine tablets Phase 3 Results Expected

Siponimod Phase 3 Results Expected

Ofatumumab Phase 3 Results Expected

VRDN-003 Phase 3 Results Expected

Tafasitamab Phase 3 Results Expected

Fingolimod Phase 3 Results Expected

Open-label rusfertide Phase 3 Results Expected

Apatinib Mesylate Phase 3 Results Expected

AMX0035 Phase 3 Results Expected

camrelizumab Phase 3 Results Expected

JSKN003 Phase 3 Results Expected

Lenalidomide Phase 3 Results Expected

placebo Phase 3 Results Expected

Bortezomib Phase 3 Results Expected

Isatuximab SAR650984 Phase 3 Results Expected

Staccato alprazolam Phase 3 Results Expected

Inavolisib Phase 3 Results Expected

NTLA-2002 Phase 3 Results Expected

OnabotulinumtoxinA Phase 3 Results Expected

mRNA-1345 Phase 3 Results Expected

Placebo Phase 3 Results Expected

LPCN 1154A Phase 3 Results Expected

Glepaglutide Phase 3 Results Expected

Fasedienol Nasal Spray Phase 3 Results Expected

VRDN-003 Phase 3 Results Expected

glepaglutide Phase 3 Results Expected

Vehicle Phase 3 Results Expected

Dexamethasone ophthalmic suspension (OCS-01) Phase 3 Results Expected

ABX464 Phase 3 Results Expected

Eplontersen Phase 3 Results Expected

ABBV-951 Phase 3 Results Expected

Efruxifermin Phase 3 Results Expected

ISL/LEN Phase 3 Results Expected

NVX-CoV2705 Phase 3 Results Expected

Low Dose (LD) RSVt vaccine Phase 3 Results Expected

Concizumab Phase 3 Results Expected

Ianalumab Phase 3 Results Expected

Cisplatin + Gemcitabine Phase 3 Results Expected

Polatuzumab Vedotin Phase 3 Results Expected

Enfortumab Vedotin Phase 3 Results Expected

Centanafadine Hydrochloride Phase 3 Results Expected

PTC923 Phase 3 Results Expected

Tremelimumab Phase 3 Results Expected

IVA Phase 3 Results Expected

Remibrutinib Phase 3 Results Expected

Prednisone Phase 3 Results Expected

Rituximab Phase 3 Results Expected

Vincristine Phase 3 Results Expected

Cyclophosphamide Phase 3 Results Expected

BNT162b2 (2025/2026 recommended SARS-CoV-2 strain) Phase 3 Results Expected

Sibeprenlimab 400 mg Phase 3 Results Expected

TAK-279 Phase 3 Results Expected

Sinovac PCV13 Phase 3 Results Expected

AZD0901 Phase 3 Results Expected

Eplontersen Phase 3 Results Expected

Ramucirumab+ paclitaxel Phase 3 Results Expected

ELIXCYTE Phase 3 Results Expected

SHR2554; Chidamide analog tablets Phase 3 Results Expected

Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected

Remimazolam Tosilate for injection Phase 3 Results Expected

XL092 Phase 3 Results Expected

Regorafenib Phase 3 Results Expected

Plozasiran Injection Phase 3 Results Expected

MM120 (LSD D-Tartrate) Phase 3 Results Expected

BHV-7000 Phase 3 Results Expected

Venglustat (GZ402671) Phase 3 Results Expected

Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution Phase 3 Results Expected

Xembify Phase 3 Results Expected

Ubrogepant Phase 3 Results Expected

Lumateperone Phase 3 Results Expected

NMRA-335140 Phase 3 Results Expected

Romiplostim Phase 3 Results Expected

Vedolizumab IV Phase 3 Results Expected

Efanesoctocog alfa Phase 3 Results Expected

Topical tacrolimus or pimecrolimus Phase 3 Results Expected

Amlitelimab Phase 3 Results Expected

Bimekizumab Phase 3 Results Expected

Topical corticosteroids Phase 3 Results Expected

RSVt Vaccine Phase 3 Results Expected

Ribociclib Phase 3 Results Expected

Durvalumab Phase 3 Results Expected

Tradipitant Phase 3 Results Expected

Alectinib Phase 3 Results Expected

Lenalidomide Phase 3 Results Expected

Fp/ABS Phase 3 Results Expected

Mosunetuzumab Phase 3 Results Expected

Rituximab Phase 3 Results Expected